PeopleBio, a company possessing technology related to the early diagnosis of Alzheimer's disease, has hit the upper price limit.
As of 2:05 PM on the 29th, PeopleBio is trading on the KOSDAQ market at 3,750 KRW, up 865 KRW (29.98%) from the previous day.
Founded in September 2002, PeopleBio is a company primarily engaged in pharmaceutical development using biotechnology, food ingredient development, chemical substance development and supply, and consulting.
The company's main product includes a blood test product that can be used for the early diagnosis of Alzheimer's disease, one of the representative degenerative brain diseases.
Currently, the Alzheimer's blood test under the AlzOn brand is being conducted at 120 medical institutions nationwide, including advanced general hospitals, health screening centers, and clinics.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
